跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 142,735 条关于
“GLP-1/amylin combination therapy”
全部
142,735
临床试验
101,969
药物
11,892
机构
1,592
资讯
27,282
5个月前
Amylin Drug Development Surges with $19 Billion Investment as Nearly 40 Programs Target Obesity Treatment
去年
Metsera's MET-233i Achieves 8.4% Weight Loss in Phase 1 Trial, Enabling First Monthly Amylin-GLP-1 Combination
去年
Verdiva Bio Advances Once-Weekly Oral GLP-1 and Amylin Therapies for Obesity Treatment
去年
AstraZeneca Presents Promising Early Data on Oral GLP-1 Agonist AZD5004 and Amylin Agonist AZD6234 for Obesity Treatment
去年
Amylin Analogs Emerge as Key Players in Next-Generation Obesity Treatments
3个月前
Pennington Biomedical Launches Clinical Trial of CagriSema, a Dual GLP-1/Amylin Weight Loss Drug Aiming to Reduce Side Effects
2年前
Novo Nordisk's Amycretin Pill Shows Promising 13% Weight Loss in Early Trial
4个月前
Innovent Unveils Next-Generation Obesity Pipeline at ADA 2026, Featuring Oral Daily and Weekly GLP-1 Candidates, Amylin Analog, and INHBE siRNA
去年
Structure Therapeutics Advances Oral Amylin Agonist ACCG-2671 for Obesity Treatment
去年
Metsera's Monthly Amylin Injection Achieves 8.4% Weight Loss in Phase I Trial
第 1 页，共 2729 页
上一页
下一页
